Understanding the efficacy and mechanism of action of cyclin dependent kinase CDK inhibitors and chemotherapeutic agents as combination therapy against human lung carcinoma

dc.contributor.guide	Joshi, Kalpana S
dc.coverage.spatial
dc.creator.researcher	Rathos, Maggie J
dc.date.accessioned	2023-10-30T03:24:23Z
dc.date.available	2023-10-30T03:24:23Z
dc.date.awarded
dc.date.completed	2013
dc.date.registered
dc.description.abstract	newlineNo newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	210p
dc.identifier.uri	http://hdl.handle.net/10603/521270
dc.language	English
dc.publisher.institution	Department of Applied Biology
dc.publisher.place	Mumbai
dc.publisher.university	University of Mumbai
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Chemotherapeutic Agents
dc.subject.keyword	Clonogenic Survival
dc.subject.keyword	Combination Therapy
dc.subject.keyword	Gefitinib
dc.subject.keyword	Life Sciences
dc.subject.keyword	Lung Carcinoma
dc.subject.keyword	Reproductive Biology
dc.title	Understanding the efficacy and mechanism of action of cyclin dependent kinase CDK inhibitors and chemotherapeutic agents as combination therapy against human lung carcinoma
dc.title.alternative
dc.type.degree	Ph.D.